Archives
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2 percent with oral semaglutide and placebo, respectively
Children With Autism More Likely to Experience Gastrointestinal Problems
Presence, number of GI symptoms linked to greater impairment in internalizing behaviors, sleep, communication, sensory processing, and repetitive behaviors
Adding Molecular Breast Imaging to DBT Beneficial for Dense Breasts
Adding MBI to digital breast tomosynthesis provided incremental cancer detection rates of 6.7 and 3.5 percent at year 1 and year 2, respectively
Guidance Issued on Impact, Management of Potassium, Phosphorus in CKD
Potassium additives may be beneficial for patients at low risk for hyperkalemia, while phosphorus additives offer no health benefits
Guidelines Developed for Postmastectomy Radiation Therapy
PMRT indicated for most with node-positive breast cancer and select patients with node-negative disease
Psilocybin-Assisted Therapy Aids Symptoms of Major Depressive Disorder
Study shows sustained remission five years posttreatment
Remote Perioperative Telemonitoring Beneficial After Cancer Surgery
Patients in the RPM care arm had a 6 percent greater functional recovery rate
Older Adults Can Regain Well-Being
Almost one in four older adults with less-than-optimal well-being at baseline regained well-being over approximately three years
Personal Storytelling During Medical Training Aids Learning
Reported benefits include being more empathetic, prepared to support patients
Oral Orforglipron Yields Greater Weight Reductions Than Placebo
Significant mean change in body weight from baseline to week 72 seen with various dosages of orforglipron compared with placebo among adults with obesity












